Related references
Note: Only part of the references are listed.Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Cbl-b Deficiency Mediates Resistance to Programmed Death-Ligand 1/Programmed Death-1 Regulation
Mai Fujiwara et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer
Heidrun Gevensleben et al.
CLINICAL CANCER RESEARCH (2016)
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng et al.
CANCER DISCOVERY (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade (vol 29, pg 285, 2016)
Haidong Tang et al.
CANCER CELL (2016)
MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets
Sudhir Kumar et al.
MOLECULAR BIOLOGY AND EVOLUTION (2016)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
Heng Yang et al.
ONCOIMMUNOLOGY (2016)
Bandage: interactive visualization ofde novogenome assemblies: Fig. 1.
Ryan R. Wick et al.
BIOINFORMATICS (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression
Brian W. Simons et al.
JOURNAL OF PATHOLOGY (2015)
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shabnam Shalapour et al.
NATURE (2015)
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Ana L. Flores-Mireles et al.
NATURE REVIEWS MICROBIOLOGY (2015)
MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer
Catherine Olesch et al.
ONCOTARGET (2015)
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Ignacio Melero et al.
NATURE REVIEWS CANCER (2015)
Diverse macrophage populations mediate acute lung inflammation and resolution
Neil R. Aggarwal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
Claire Germain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Rituximab for treating CD20+prostate cancer with generalized lymphadenopathy: a case report and review of the literature
Angus Dalgleish et al.
INVESTIGATIONAL NEW DRUGS (2014)
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon et al.
LANCET ONCOLOGY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
α-Catenin is an inhibitor of transcription
Rebecca L. Daugherty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy
M. Lanciotti et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Exomics and immunogenics Bridging mutational load and immune checkpoints efficacy
Stephane Champiat et al.
ONCOIMMUNOLOGY (2014)
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp et al.
ONCOIMMUNOLOGY (2014)
The Role and Regulation of Human Th17 Cells in Tumor Immunity
Jian Ye et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Genetic markers associated with early cancer-specific mortality following prostatectomy
Wennuan Liu et al.
CANCER (2013)
Prevalence and Characteristics of the Epidemic Multiresistant Escherichia coli ST131 Clonal Group among Extended-Spectrum Beta-Lactamase-Producing E. coli Isolates in Copenhagen, Denmark
Bente Olesen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu et al.
NATURE BIOTECHNOLOGY (2013)
Th1-Th17 Cells Contribute to the Development of Uropathogenic Escherichia coli-Induced Chronic Pelvic Pain
Marsha L. Quick et al.
PLOS ONE (2013)
Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
Marsha L. Quick et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage
Justyna Bien et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2012)
Uropathogenic Escherichia coli Induces Chronic Pelvic Pain
Charles N. Rudick et al.
INFECTION AND IMMUNITY (2011)
Diversity of Cervicovaginal Microbiota Associated with Female Lower Genital Tract Infections
Zongxin Ling et al.
MICROBIAL ECOLOGY (2011)
Distribution of Foxp3-, CD4-and CD8-positive lymphocytic cells in benign and malignant prostate tissue
Alexander Valdman et al.
APMIS (2010)
Engineering the perfect (bacterial) cancer therapy
Neil S. Forbes
NATURE REVIEWS CANCER (2010)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters
Kathleen Ebelt et al.
EUROPEAN JOURNAL OF CANCER (2009)
Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma
Mahmoud-Rezk A. Hussein et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Urothelial Cultures Support Intracellular Bacterial Community Formation by Uropathogenic Escherichia coli
Ruth E. Berry et al.
INFECTION AND IMMUNITY (2009)
PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
C. A. Crane et al.
ONCOGENE (2009)
Human Prostate-Infiltrating CD8+ T Lymphocytes are Oligoclonal and PD-I+
Karen S. Sfanos et al.
PROSTATE (2009)
CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides
Tahamtan Ahmadi et al.
IMMUNOLOGY (2008)
Sex and virulence in Escherichia coli:: an evolutionary perspective
Thierry Wirth et al.
MOLECULAR MICROBIOLOGY (2006)
Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line
PA Watson et al.
CANCER RESEARCH (2005)
FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function
V Brinkmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Dynamics of nasopharyngeal colonization by potential respiratory pathogens
JA García-Rodríguez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Functional significance of the perforin/granzyme cell death pathway
JA Trapani et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Artemis: sequence visualization and annotation
K Rutherford et al.
BIOINFORMATICS (2000)
Rapid and simple determination of the Escherichia coli phylogenetic group
O Clermont et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)